BIIB vs SWK · P/E 21, rev $9.89B vs P/E 34, rev $7.81B
Biogen Inc (BIIB) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the BIIB and SWK stock pages for the full models.
Not investment advice.